International Journal of Medical Microbiology
Tick-borne encephalitis virus natural foci emerge in western Sweden
Introduction
The tick-borne encephalitis virus (TBEV) belongs to the family of Flaviviridae. The TBE complex shares 77–98% amino acid similarity in the E protein, making this protein region a prime target for sequencing in phylogeny studies (Gao et al., 1993; Mandl et al., 1993). There are three subtypes of TBE: Far Eastern (FE), Siberian (Sib), and West-European (WE) (Wallner et al., 1996; Gritsun et al., 2003b; Pogodina et al., 2004). In Europe and Siberian Russia, TBEV is a high-impact CNS pathogen with approximately 12,000 diagnoses annually (Günther and Haglund, 2005). The virus causes a variety of clinical manifestations, with neurological manifestations in up to 30% of the patients (Gustafson et al., 1993). Lethality of WE-TBEV found in Europe is <2%, but post-encephalitic syndrome is seen in over 40% of the infected patients, often severely impairing their quality of life (Günther et al., 1997). Antiviral treatment is currently lacking, although two vaccines are available that effectively prevent TBEV infection (Heinz et al., 1980; Klockmann et al., 1991).
In Scandinavia, the first reports of TBE from Sweden, Finland, Denmark, and Norway date back to 1954, 1956, 1963, and 1997, respectively (Skarpaas et al., 2006). In Sweden, routine TBEV surveillance since 1956 and neutralizing antibody assays of TBEV on cattle sera in the 1950s placed most TBE natural foci around Stockholm though recent years have seen TBE spread north and west (von Zeipel et al., 1959; Lindgren and Gustafson, 2001; Haglund, 2002). Annually, Sweden reports >100 cases each year, and that number is rising. In the western Gotaland region, situated at the south-western part of Sweden, TBE was previously a non-existent or unnoticed human disease. During the last decade, however, a growing number of cases have been diagnosed, making TBEV one of the most threatening emerging diseases in the investigated region.
TBEV in Sweden is transmitted largely by Ixodes ricinus hard ticks, which can live for 2–5 years. TBEV spreads to ticks when they feed either on viremic or non-viremic animals (Labuda et al., 1993a, Labuda et al., 1997; Randolph et al., 1999; Gritsun et al., 2003a). Vertical transstadial and sexual transmission can occur among both ticks and warm-blooded hosts (Molnarova and Mayer, 1980; Khozinsky et al., 1985). Once infected, the tick remains infected throughout its life cycle (Kožuch and Nosek, 1980; Nosek et al., 1986; Rosa et al., 2003).
The low-endemic region of western Gotaland is well-suited for studies on the epidemiology of TBEV. In addition to routine surveillance of TBE cases and seroprevalence studies, determining TBEV prevalence in free-living tick populations and quantities of TBEV RNA in ticks helps verify TBE foci, assess the transmission risk from a tick bite, and predict the epidemiology of the disease for immunoprophylactic strategies. For this purpose, samples of ticks were collected from different parts of western Gotaland, the front of the epidemic. Additionally, TBEV from western Gotaland was phylogenetically analyzed to trace the origin of the TBEV spread in that region.
Section snippets
Collection of ticks
All TBE locations were selected on the basis of interviews with TBE patients about suspected areas where they had contracted TBE (Table 1). Four different locations were chosen from areas where more than 5 patients had contracted TBE in the past 10 years (Fig. 1). In total, 4 TBE locations were sampled and 2 control areas (Fig. 1). Areas where pools of questing ticks were collected are detonated with ‘T’, while ticks taken from cows were labeled ‘C’ (Fig. 1). Annual precipitation was in the
PCR methodology
The methodology used to detect TBEV RNA in the tick population was found to be reliable, sensitive, and yielded optimal results when compared to other methods. Such sensitivity is key as the amount of virus present may be extremely low at the time of testing due to freezing and thawing of the samples, replication cycle of the virus, or the decrease in viral copy numbers depending on the developmental stage in ticks (Kožuch and Nosek, 1985; Puchhammer-Stöckl et al., 1995).
Previous studies (
Discussion
This is the first time to our knowledge that TBEV copy numbers have been recorded in ticks by RT-PCR. The extreme range of viral copy numbers, from 500 to over 109, may give clues to why some TBE cases are more severe than others. One can assume that a tick with high TBEV copy numbers would have a higher likelihood of infecting a human and could possibly transmit disease with higher neurovirulence. There could be several factors that affect how ticks could acquire such high viral copy numbers:
Acknowledgments
We thank Sirkka Vene for technical advice; the detection and quantification department of Sahlgrenska Hospital for technical assistance; Jan Carlsson, Reiman Franksson, and Strömmaskolan for assistance with cows; and Oskar Roshed and Inger Karlsson for help in tick collecting. Financial support was received from the VästraGötaland Research Fund.
References (46)
- et al.
Extension of Ixodes ricinus ticks and agents of tick-borne diseases to mountain areas in the Czech Republic
Int. J. Med. Microbiol.
(2006) - et al.
Classification of a new member of the TBE flavivirus subgroup by its immunological, pathogenetic and molecular characteristics: identification of subgroup-specific pentapeptides
Virol. Res.
(1993) - et al.
Tick-borne encephalitis
Antivir. Res.
(2003) - et al.
Tick-borne flaviviruses
Adv. Virol. Res.
(2003) - et al.
Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome
Clin. Diag. Virol.
(1997) Occurrence of TBE in areas previously considered being non-endemic: Scandinavian data generate an international study by the International Scientific Working Group for TBE (ISW-TBE)
Int. J. Med. Microbiol.
(2002)- et al.
Studies on TBE epidemiology in Finland (and Lithuania)
Int. J. Med. Microbiol.
(2002) - et al.
Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization
Vaccine
(1991) - et al.
The golden agers and tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on Tick-borne encephalitis
Vaccine
(2006) - et al.
Tick-borne encephalitis virus transmission between ticks cofeeding on specific immune natural rodent hosts
Virology
(1997)